Is Brainsway Ltd. (BWAY) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 1.2% / 30% | 14.3% / 30% | 0.9% / 30% | 6.04% / 5% | ✗ NOT HALAL |
| DJIM | 1.2% / 33% | 14.3% / 33% | 0.9% / 33% | 6.04% / 5% | ✗ NOT HALAL |
| MSCI | 6.0% / 33% | 73.5% / 33% | 4.9% / 33% | 6.04% / 5% | ✗ NOT HALAL |
| S&P | 1.2% / 33% | 14.3% / 33% | 0.9% / 33% | 6.04% / 5% | ✗ NOT HALAL |
| FTSE | 6.0% / 33% | 73.5% / 33% | 4.9% / 50% | 6.04% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 75.4% | |
| Operating Margin | 13.2% | |
| Net Margin | 14.6% | |
| Return on Equity (ROE) | 11.3% | |
| Return on Assets (ROA) | 2.6% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $18M |
| Free Cash Flow | $16M |
| Total Debt | $7M |
| Debt-to-Equity | 9.3 |
| Current Ratio | 3.8 |
| Total Assets | $113M |
Price & Trading
| Last Close | $13.49 |
| 50-Day MA | $12.32 |
| 200-Day MA | $8.82 |
| Avg Volume | 207K |
|
52-Week Range
$3.92
| |
About Brainsway Ltd. (BWAY)
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Brainsway Ltd. (BWAY) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Brainsway Ltd. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Brainsway Ltd.'s debt ratio?
Brainsway Ltd.'s debt ratio is 1.2% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 6.0%.
What are Brainsway Ltd.'s key financial metrics?
Brainsway Ltd. has a market capitalization of $515M, trailing P/E ratio of 71.5, and revenue of $52M. The company maintains a gross margin of 75.4% and a net margin of 14.6%. Return on equity stands at 11.3%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.